PRA Health Sciences Return on Equity

PRA Health Sciences (PRAH) currently reports a ROE of 13.71%. That is below the Healthcare sector average of 29.33%. Use the charts on this page to explore PRA Health Sciences's ROE history and peer comparisons.

PRA Health Sciences's ROE of 13.71% is lower than the Healthcare sector average of 29.33%. That is roughly 53.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but PRA Health Sciences's current 13.71% should be judged against Healthcare norms (sector average: 29.33%) and against PRAH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 13.71%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.33%. From there, open related valuation or income-statement pages for PRA Health Sciences, and consider following PRAH for alerts when major investors trade the stock.

PRA Health Sciences is classified in the Healthcare sector. On ROE, it currently shows 13.71% versus a sector average near 29.33%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PRAH with unrelated industries.